Opportunity Information: Apply for RFA DA 19 019

The HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R43/R44 - Clinical Trial Optional) grant opportunity (Funding Opportunity Number RFA-DA-19-019) is a National Institutes of Health program led by the National Institute on Drug Abuse (NIDA) that uses the SBIR mechanism to fund small businesses developing practical, research-driven technologies aimed at addressing the opioid crisis. The central goal is to accelerate innovations that can prevent opioid misuse, improve treatment and recovery outcomes, reduce overdose deaths, and lessen the broader harms opioids have caused to individuals, families, and communities. The program sits within the broader NIH HEAL (Helping to End Addiction Long-term) Initiative, which focuses on speeding up scientific solutions to addiction and pain.

This opportunity is structured around the SBIR R43/R44 pathway, meaning it supports both early-stage feasibility work and more advanced development toward commercialization. In practice, applicants can propose Phase I-type activities (proof of concept, prototype feasibility, early validation) and Phase II-type activities (further R and D, refinement, scaling, and preparation for real-world implementation). The "clinical trial optional" designation indicates that projects may include clinical trial work if it is appropriate for the technology and stage of development, but applicants are not required to run a clinical trial to be eligible. The program is positioned for companies building tangible products or technology-enabled services that translate research into deployable tools, consistent with NIDA's research and development mission and the FOA's stated topical areas.

Eligibility is limited to United States small business concerns that meet SBIR requirements and have the technical capacity to carry out the proposed research and development. Foreign institutions (non-U.S. entities) are not eligible to apply, and non-U.S. components of U.S. organizations are also not eligible. However, "foreign components" as defined by the NIH Grants Policy Statement may be permitted, which typically means a portion of the work can occur outside the U.S. under specific circumstances and with appropriate justification and approvals, while the applicant organization itself must remain a U.S. small business.

From an administrative standpoint, this is a discretionary grant program under the NIH, categorized under education and health, with CFDA numbers 93.279 and 93.350. The opportunity was created on 2018-12-10 and had an original closing date of 2021-09-08. While the provided source data does not list an award ceiling or the expected number of awards, the intent is clearly to fund multiple small business projects that can contribute meaningful, scalable solutions to the opioid epidemic through technology development and related translational research.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R43/R44 - Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279, 93.350.
  • This funding opportunity was created on 2018-12-10.
  • Applicants must submit their applications by 2021-09-08. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Small businesses.
Apply for RFA DA 19 019

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more business programs for Business Consultants

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Heal Initiative: Pragmatic Randomized Controlled Trial of Acupuncture for Management of Chronic Low Back Pain in Older Adults (UG3/UH3 Clinical Trial Required)

Previous opportunity: Resource Based Geospatial and Enterprise GIS Support

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DA 19 019

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DA 19 019) also looked into and applied for these:

Funding Opportunity
HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R41/R42 - Clinical Trial Optional) Apply for RFA DA 19 020

Funding Number: RFA DA 19 020
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Clinical Research Centers (UG1 Clinical Trial Optional) Apply for RFA DA 19 025

Funding Number: RFA DA 19 025
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,500,000
HEAL Initiative Limited Competition: Behavioral Research to Improve MAT: Ancillary Studies to Enhance Behavioral or Social Interventions to Improve Adherence to Medication Assisted Treatment for Opioid Use Disorders (R01, Clinical Trials Optional) Apply for RFA AT 19 007

Funding Number: RFA AT 19 007
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $400,000
HEAL Initiative: Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (U01 Clinical Trial Optional) Apply for RFA HL 19 029

Funding Number: RFA HL 19 029
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $750,000
HEAL Initiative: Effectiveness Trials to Optimize, Implement, Scale, and Sustain the Collaborative Care Model for Individuals with Opioid Use Disorders and Mental Health Conditions (U01 Clinical Trial Required) Apply for RFA MH 19 525

Funding Number: RFA MH 19 525
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HEAL Initiative: Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (R01 - Clinical Trial Not Allowed) Apply for RFA HL 19 028

Funding Number: RFA HL 19 028
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $350,000
Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional) Apply for PAR 19 101

Funding Number: PAR 19 101
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $499,999
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) Apply for PAR 19 113

Funding Number: PAR 19 113
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $400,000
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional) Apply for PA 19 111

Funding Number: PA 19 111
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional) Apply for PA 19 112

Funding Number: PA 19 112
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed) Apply for PA 19 130

Funding Number: PA 19 130
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Laboratories for Early Clinical Evaluation of Pharmacotherapies for Substance Use Disorders (UG1 Clinical Trial Required) Apply for RFA DA 19 018

Funding Number: RFA DA 19 018
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required) Apply for PAR 19 133

Funding Number: PAR 19 133
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional) Apply for PAR 19 136

Funding Number: PAR 19 136
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R41/R42 - Clinical Trial Not Allowed) Apply for RFA DA 19 030

Funding Number: RFA DA 19 030
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R43/R44 - Clinical Trial Not Allowed) Apply for RFA DA 19 031

Funding Number: RFA DA 19 031
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) Apply for RFA CA 19 028

Funding Number: RFA CA 19 028
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed) Apply for PAR 19 147

Funding Number: PAR 19 147
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Drug Discovery For Nervous System Disorders (R21 Clinical Trial Not Allowed) Apply for PAR 19 146

Funding Number: PAR 19 146
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Bioengineering Research Grants (BRG) (R01 Clinical Trial Required) Apply for PAR 19 159

Funding Number: PAR 19 159
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 19 019", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: